HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Falini, B. Articles by Martelli, M. F. Search for Related Content PubMed PubMed Citation Articles by Falini, B. Articles by Martelli, M. F.

Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias

From the Section of Hematology and Immunology, University of Perugia, IBit Foundation, Perugia, Italy (BF, NB, PG, CM, MFM); Institute of Internal Medicine, University of Perugia, Perugia, Italy (IN); Institute of Hematology, University of Bari, Bari, Italy (MPM); Institute of Hematology, University of Foggia, Foggia, Italy (AL); Institute of Hematology, University "La Sapienza", Rome, Italy (FM).

Correspondence: Professor Brunangelo Falini, Institute of Hematology, Policlinico Monteluce, 06122 Perugia, Italy. E-mail: faliniem{at}unipg.it

Nucleophosmin (NPM) is a ubiquitously expressed nucleolar phoshoprotein which shuttles continuously between the nucleus and cytoplasm. Many findings have revealed a complex scenario of NPM functions and interactions, pointing to proliferative and growth-suppressive roles of this molecule. The gene NPM1 that encodes for nucleophosmin (NPMI) is translocated or mutated in various lymphomas and leukemias, forming fusion proteins (NPM-ALK, NPM-RARa, NPM-MLF1) or NPM mutant products. Here, we review the structure and functions of NPM, as well as the biological, clinical and pathological features of human hematologic malignancies with NPM1 gene alterations. NPM-ALK indentifies a new category of T/Null lymphomas with distinctive molecular and clinicopathological features, that is going to be included as a novel disease entity (ALK+ anaplastic large cell lymphoma) in the new WHO classification of lymphoid neoplasms. NPM1 mutations occur specifically in about 30% of adult de novo AML and cause aberrant cytoplasmic expression of NPM (hence the term NPMc+ AML). NPMc+ AML associates with normal karyotpe, and shows wide morphological spectrum, multilineage involvement, a unique gene expression signature, a high frequency of FLT3-internal tandem duplications, and distinctive clinical and prognostic features. The availability of specific antibodies and molecular techniques for the detection of NPM1 gene alterations has an enormous impact in the biological study diagnosis, prognostic stratification, and monitoring of minimal residual disease of various lymphomas and leukemias. The discovery of NPM1 gene alterations also represents the rationale basis for development of molecular targeted drugs.

Key words: nucleophosmin, NPM mutations, lymphomas, ALK, acute myeloid leukemia, normal karyotype, ARF, antibodies.

This article has been cited by other articles:

				A. Liso, F. Castiglione, A. Cappuccio, F. Stracci, R. F. Schlenk, S. Amadori, C. Thiede, S. Schnittger, P. J.M. Valk, K. Dohner, et al. A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) Haematologica, August 1, 2008; 93(8): 1219 - 1226. [Abstract] [Full Text] [PDF]

				S. J. Leuenroth and C. M. Crews Triptolide-Induced Transcriptional Arrest Is Associated with Changes in Nuclear Substructure Cancer Res., July 1, 2008; 68(13): 5257 - 5266. [Abstract] [Full Text] [PDF]

				B. Falini, M. P. Martelli, C. Mecucci, A. Liso, N. Bolli, B. Bigerna, A. Pucciarini, S. Pileri, G. Meloni, M. F. Martelli, et al. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice Haematologica, May 1, 2008; 93(5): 775 - 779. [Abstract] [Full Text] [PDF]

				M. Okuwaki The Structure and Functions of NPM1/Nucleophsmin/B23, a Multifunctional Nucleolar Acidic Protein J. Biochem., April 1, 2008; 143(4): 441 - 448. [Abstract] [Full Text] [PDF]

				B. Falini, C. Mecucci, G. Saglio, F. L. Coco, D. Diverio, P. Brown, F. Pane, M. Mancini, M. P. Martelli, S. Pileri, et al. NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia Haematologica, March 1, 2008; 93(3): 439 - 442. [Abstract] [Full Text] [PDF]

				Y. Zou, J. Wu, R. J. Giannone, L. Boucher, H. Du, Y. Huang, D. K. Johnson, Y. Liu, and Y. Wang Nucleophosmin/B23 Negatively Regulates GCN5-dependent Histone Acetylation and Transactivation J. Biol. Chem., February 29, 2008; 283(9): 5728 - 5737. [Abstract] [Full Text] [PDF]